Quarterly report pursuant to Section 13 or 15(d)

Significant Balance Sheet Components

v3.24.2.u1
Significant Balance Sheet Components
6 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Significant Balance Sheet Components

NOTE 4 — Significant Balance Sheet Components

 

The following table presents the components of the Company’s receivables:

 

Schedule of Accounts Receivable 

    June 30, 2024     December 31, 2023  
Trade receivables   $ 11,053     $ 25,576  
Allowance for credit losses     (272 )     (272 )
Accounts receivable, net     10,781       25,304  
Non-trade receivables     2,198       961  
Total accounts receivable   $ 12,979     $ 26,265  

 

The Company has non-trade receivables from manufacturing vendors resulting from the sale of components to vendors who manufacture and assemble final products for the Company.

 

The Company determines the probability of default for each pool of receivables with similar risk characteristics. The probability of loss is applied to the value of the receivables and an allowance for potential credit losses is recorded with the offset to credit loss expense.

 

Trade receivables from the customer that purchased white label tablets from the Company accounts for 25% and 69%, respectively, of accounts receivable, net, at June 30, 2024, and December 31, 2023. One additional customer that purchased white label phones from the Company accounts for 25% of accounts receivable, net, at June 30, 2024, and another customer accounts for 17% of accounts receivable, net, at June 30, 2024. A separate customer accounts for 13% and 15% of accounts receivable, net, at June 30, 2024, and December 31, 2023, respectively. In October 2023, the Company stopped sales of the white label tablets to its tablet customer as the product reached the end of its life cycle. The tablet customer had a receivable due to the Company of $17,443 at December 31, 2023. In February 2024, an agreement was executed that transferred $11,308 of the receivables to the manufacturer of the tablets in exchange for relieving the Company of a $11,308 accounts payable liability.

 

 

The following table presents the components of the Company’s inventory:

 

Schedule of Inventory 

    June 30, 2024     December 31, 2023  
Devices – for resale   $ 4,275     $        5,324  
Raw materials     2,340       751  
Accessories     405       442  
Inventory, net   $ 7,020     $ 6,517  

 

The Company purchases raw materials in bulk to obtain a lower price and to ensure availability. The raw materials are resold to third-party manufacturers.

 

Distributor returns allowance

 

The Company records reductions to Cost of Revenues related to future distributor product returns based on the Company’s expectation.

 

The following table presents the components of the Company’s other assets:

 

Schedule of Other Assets 

    June 30, 2024     December 31, 2023  
Advances to third-party manufacturers   $ 2,000     $ 2,000  
Other     1,011       898  
Total other assets   $ 3,011     $ 2,898  

 

The following table presents the components of the Company’s accrued liabilities:

 

Schedule of Accrued Expenses 

    June 30, 2024     December 31, 2023  
Customer allowances   $ 10,280     $ 8,148  
Contract fulfillment liabilities     2,374       568  
Inventory received, not billed     2,198       325  
Employee-related liabilities     729       1,755  
Warranties     550       518  
Other     1,583       919  
Accrued liabilities   $ 17,714     $ 12,233